(CRVS) Corvus Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Corvus Pharmaceuticals | (CRVS) share price targets
Complete technical analysis of Corvus Pharmaceuticals (CRVS) by charts plus indicators, forecast predictions and share price targets for Corvus Pharmaceuticals (CRVS)
Corvus Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2025-06-06 View latest technical analysis
10 day averaged volume of Corvus Pharmaceuticals is 673180
| Date | Daily Closing Price | Open | High | Low | Volume |
| 06 Fri Jun 2025 | 3.91 | 3.94 | 4.16 | 3.91 | 1.125 times |
| 05 Thu Jun 2025 | 3.91 | 3.81 | 3.95 | 3.72 | 0.7 times |
| 04 Wed Jun 2025 | 3.75 | 4.00 | 4.36 | 3.70 | 1.767 times |
| 03 Tue Jun 2025 | 4.12 | 4.02 | 4.22 | 3.98 | 1.098 times |
| 02 Mon Jun 2025 | 4.03 | 3.78 | 4.03 | 3.73 | 1.199 times |
| 30 Fri May 2025 | 3.78 | 3.80 | 3.84 | 3.68 | 0.756 times |
| 29 Thu May 2025 | 3.80 | 3.83 | 3.94 | 3.75 | 0.99 times |
| 28 Wed May 2025 | 3.78 | 3.67 | 3.81 | 3.62 | 0.88 times |
| 27 Tue May 2025 | 3.67 | 3.52 | 3.72 | 3.49 | 1.107 times |
| 23 Fri May 2025 | 3.49 | 3.46 | 3.51 | 3.38 | 0.691 times |
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 4 as stoploss in an intra day sell trade for a target of 3.79. However, stock will show a bullish move above 4.
Share price targets for Corvus Pharmaceuticals (CRVS)
| Target Type | Value |
| Downside Target | 2.54 |
| Downside Target | 3.08 |
| Downside Target | 3.17 |
| Downside Target | 3.38 |
| Downside Target | 3.46 |
| Downside Target | 3.70 |
| Downside Target | 3.78 |
| Upside Target | 3.94 |
| Upside Target | 4.36 |
| Upside Target | 4.49 |
| Upside Target | 4.53 |
| Upside Target | 4.80 |
| Upside Target | 5.65 |
Intraday share price targets for Corvus Pharmaceuticals (CRVS)
| Target Type | Value |
| Downside Intraday Target | 3.62 |
| Downside Intraday Target | 3.33 |
| Upside Intraday Target | 4.28 |
| Upside Intraday Target | 4.65 |
| Upside Intraday Target | 3.99 |
Weekly technical analysis of Corvus Pharmaceuticals (CRVS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 06 Fri Jun 2025 | 3.91 | 3.78 | 4.36 | 3.70 | 1.578 times |
| 30 Fri May 2025 | 3.78 | 3.52 | 3.94 | 3.49 | 0.797 times |
| 23 Fri May 2025 | 3.49 | 3.56 | 3.79 | 3.38 | 0.503 times |
| 16 Fri May 2025 | 3.61 | 4.42 | 4.53 | 3.46 | 0.401 times |
| 09 Fri May 2025 | 4.43 | 3.58 | 4.49 | 3.17 | 3.773 times |
Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Corvus Pharmaceuticals (CRVS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 06 Fri Jun 2025 | 3.91 | 3.78 | 4.36 | 3.70 | 0.135 times |
| 30 Fri May 2025 | 3.78 | 3.58 | 4.53 | 3.17 | 1.64 times |
| 30 Wed Apr 2025 | 3.59 | 3.22 | 3.78 | 2.54 | 1.648 times |
| 31 Mon Mar 2025 | 3.18 | 4.10 | 4.80 | 3.08 | 1.037 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Corvus Pharmaceuticals (CRVS)
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Corvus Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Corvus Pharmaceuticals in short term and the buy signal is strong.
Corvus Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a buy signal for Corvus Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Corvus Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.83 and Corvus Pharmaceuticals (CRVS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Corvus Pharmaceuticals (CRVS) stock. Volume based technical analysis of Corvus Pharmaceuticals (CRVS) stock is negative.
Corvus Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Corvus Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Corvus Pharmaceuticals in short term and the buy signal is strong.
Corvus Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a buy signal for Corvus Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Corvus Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.83 and Corvus Pharmaceuticals (CRVS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Corvus Pharmaceuticals (CRVS) stock. Volume based technical analysis of Corvus Pharmaceuticals (CRVS) stock is negative.
Corvus Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.